Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Case Report Volume 3 Issue 2

Ciprofloxacin-Induced Psychosis with Pseudobulbar Affect in A Patient with End-Stage Renal Disease

Robert A Weir*

Department of Psychiatry, Harry Hines Blvd, Dallas, Texas

*Corresponding Author: Robert A Weir, Department of Psychiatry, Harry Hines Blvd, Dallas, Texas.

Received: January 18, 2020 Published: January 24, 2020

×

Abstract

  New-onset psychosis in mid to late life is an interesting and uncommon phenomenon. Typically, onset of psychosis is during adolescence. Earlier manifestations (childhood) and later manifestations (after 45 years old) are rare, as men tend to be diagnosed between 18 - 25 and women between 25 - 35 (albeit with a second peak noted near menopause). Clinicians should be wary when new psychotic symptoms develop in a patient outside of these peak times, as psychiatric diagnoses often follow a patient lifelong, prompting treatment with chronic medications that carry a risk of significant side effects. Below, I present a case of new-onset psychosis and pseudobulbar affect (PBA) secondary to ciprofloxacin that without prudent investigation may have ended up receiving inpatient psychiatric treatment and chronic psychotropic medication for a chronic psychiatric condition she did not ultimately have. The complication of PBA is one that has not yet, to my knowledge, been documented in the literature to date.

Keywords: Ciprofloxacin; Psychosis; Pseudobulbar; Fluoroquinolone

×

Citation

Citation: Robert A Weir. “Ciprofloxacin-Induced Psychosis with Pseudobulbar Affect in A Patient with End-Stage Renal Disease".Acta Scientific Neurology 3.2 (2020): 50-53.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US